Imaging of human infection with (131)I-labeled recombinant human interleukin-8

J Nucl Med. 2001 Nov;42(11):1656-9.

Abstract

The chemotactic cytokine interleukin-8 (IL-8) plays an important role in attraction and activation of polymorphonuclear leukocytes in infection and inflammation. A pilot study was conducted to determine if radiolabeled IL-8 would depict infection in humans.

Methods: Human recombinant IL-8 (rhIL-8) labeled with (131)I (specific activity, 0.4-0.7 MBq [11-18 microCi] (131)I/microg IL-8) was injected intravenously into 8 diabetic patients with active foot infections and evidence of osteomyelitis, 2 patients with successfully treated osteomyelitis, and 1 patient with cellulitis of the thumb.

Results: Focal accumulation of (131)I-rhIL-8 was seen in 8 of 8 patients with active foot infection and diffuse uptake was seen in the thumb of the 1 patient with cellulitis. In the 2 patients with successfully treated bone infection, multiphase (99m)Tc-hydroxyethylene diphosphonate bone scans were negative early, but late-phase (>3 h) uptake depicted degenerative lesions that did not image with (131)I-rhIL-8.

Conclusion: (131)I-rhIL-8 accumulates rapidly within infected foci in osteomyelitis and cellulitis but not in successfully treated infections or degenerative joint disease.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Diabetes Complications
  • Diabetic Foot / diagnostic imaging
  • Female
  • Humans
  • Image Processing, Computer-Assisted
  • Infections / diagnostic imaging*
  • Interleukin-8* / pharmacokinetics
  • Iodine Radioisotopes
  • Male
  • Middle Aged
  • Osteomyelitis / diagnostic imaging
  • Radionuclide Imaging
  • Radiopharmaceuticals* / pharmacokinetics
  • Recombinant Proteins / pharmacokinetics

Substances

  • Interleukin-8
  • Iodine Radioisotopes
  • Radiopharmaceuticals
  • Recombinant Proteins